Moreover, FSP1 operates independently of the GPX4–GSH system, suggesting that co-targeting FSP1 and GPX4 may synergistically trigger ferroptosis and circumvent tumor cell survival mechanisms. The gene discussed is AIFM2; the disease is neoplasm.